Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception
Open Access
- 29 June 2015
- Vol. 7 (7), 2435-2453
- https://doi.org/10.3390/toxins7072435
Abstract
Botulinum neurotoxins (BoNTs) have been widely used to treat a variety of clinical ailments associated with pain. The inhibitory action of BoNTs on synaptic vesicle fusion blocks the releases of various pain-modulating neurotransmitters, including glutamate, substance P (SP), and calcitonin gene-related peptide (CGRP), as well as the addition of pain-sensing transmembrane receptors such as transient receptor potential (TRP) to neuronal plasma membrane. In addition, growing evidence suggests that the analgesic and anti-inflammatory effects of BoNTs are mediated through various molecular pathways. Recent studies have revealed that the detailed structural bases of BoNTs interact with their cellular receptors and SNAREs. In this review, we discuss the molecular and cellular mechanisms related to the efficacy of BoNTs in alleviating human pain and insights on engineering the toxins to extend therapeutic interventions related to nociception.Keywords
Funding Information
- National Research Foundation of Korea (2013R1A1A2005836, 2013R1A1A3A04006010)
This publication has 111 references indexed in Scilit:
- Emerging Opportunities for Serotypes of Botulinum NeurotoxinsToxins, 2012
- Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future DevelopmentsToxins, 2012
- Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked ComplexScience, 2012
- Central Action of Peripherally Applied Botulinum Toxin Type A on Pain and Dural Protein Extravasation in Rat Model of Trigeminal NeuropathyPLOS ONE, 2012
- Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays BotulismJournal of Biological Chemistry, 2011
- Receptor Binding Enables Botulinum Neurotoxin B to Sense Low pH for Translocation Channel AssemblyCell Host & Microbe, 2011
- Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherinThe Journal of cell biology, 2010
- Crystallization and preliminary X-ray analysis of the HA3 component ofClostridium botulinumtype C progenitor toxinActa Crystallographica Section F Structural Biology and Crystallization Communications, 2007
- Single molecule detection of intermediates during botulinum neurotoxin translocation across membranesProceedings of the National Academy of Sciences, 2007
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006